moxifloxacin has been researched along with Innate Inflammatory Response in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Donnenfeld, ED; Hovanesian, JA | 1 |
| Baratz, KH; Farazdaghi, MK; Patel, SV; Tailor, PD | 1 |
| Jeeva, IK; Masud, S; Siddiqui, MAR | 1 |
| Chang, MC; Chen, KY; Hung, KH; Kuo, YJ; Peng, CL; Yeh, LK | 1 |
| Hwang, FS; Kim, J; LeClair, B; Nassiri, S; Pham, M; Rauser, ME; Yoon, E | 1 |
| Borggren, M; Nygart, JF; Nygart, VA; Tvede, M | 1 |
| Bals, R; Beisswenger, C; Bischoff, M; Honecker, A; Kamyschnikow, A; Tschernig, T | 1 |
| Chikosi, SJ; Jungck, D; Knobloch, J; Koch, A; Rupp, J; Yanik, S | 1 |
| Alcantara-Warren, C; Archbald-Pannone, L; Carman, RJ; Genheimer, CW; Gerding, DN; Guerrant, RL; Lyerly, D; Pawlowski, SW | 1 |
| Liu, YN; Wang, D; Wang, Y | 1 |
| Cetinkaya, Z; Ermis, SS; Kiyici, H; Ozturk, F | 1 |
| Belfort, R; Freitas, LL; Höfling-Lima, AL; Muccioli, C; Soriano, E | 1 |
| Buommino, E; Cozza, V; Donnarumma, G; Iovene, MR; Paoletti, I; Tudisco, L; Tufano, MA | 1 |
| Andrews, JM; Hartman, G; Marshall, G; Wise, R | 1 |
3 trial(s) available for moxifloxacin and Innate Inflammatory Response
| Article | Year |
|---|---|
Intracameral dexamethasone 9% vs prednisolone acetate 1% in controlling postoperative pain and inflammation in patients undergoing cataract surgery.
Topics: Cataract; Cataract Extraction; Dexamethasone; Humans; Inflammation; Moxifloxacin; Ophthalmic Solutions; Pain, Postoperative; Phacoemulsification; Postoperative Complications; Prednisolone; Prospective Studies | 2022 |
Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial.
Topics: Aged; Anti-Infective Agents; Antineoplastic Agents, Hormonal; Aza Compounds; Dexamethasone; Double-Blind Method; Drug Combinations; Female; Fluoroquinolones; Humans; Inflammation; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; No-Observed-Adverse-Effect Level; Phacoemulsification; Postoperative Complications; Quinolines | 2007 |
Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Humans; Inflammation; Injections, Intravenous; Male; Moxifloxacin; Quinolines | 1999 |
11 other study(ies) available for moxifloxacin and Innate Inflammatory Response
| Article | Year |
|---|---|
Oleander-Associated Keratitis and Uveitis.
Topics: Corneal Edema; Cyclopentolate; Female; Humans; Inflammation; Keratitis; Middle Aged; Moxifloxacin; Nerium; Prednisolone; Prednisone; Uveitis, Anterior | 2022 |
Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country - a one-year audit.
Topics: Adult; Aged; Cataract; Cataract Extraction; Developing Countries; Endophthalmitis; Eye Diseases; Female; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Retrospective Studies; Triamcinolone | 2023 |
Liposomal dexamethasone-moxifloxacin nanoparticle combinations with collagen/gelatin/alginate hydrogel for corneal infection treatment and wound healing.
Topics: Alginates; Animals; Anti-Inflammatory Agents; Bacillus; Biocompatible Materials; Collagen; Cornea; Corneal Diseases; Dexamethasone; Drug Delivery Systems; Edema; Epithelial Cells; Escherichia coli; Gelatin; Humans; Hydrogels; Inflammation; Lipids; Liposomes; Mice; Mice, Inbred C57BL; Moxifloxacin; Particle Size; Time Factors; Wound Healing | 2020 |
Comparative analysis of intravitreal triamcinolone acetonide-moxifloxacin versus standard perioperative eyedrops in cataract surgery.
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Corneal Edema; Drug Combinations; Female; Glucocorticoids; Humans; Inflammation; Intraocular Pressure; Intravitreal Injections; Lens Implantation, Intraocular; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Retrospective Studies; Triamcinolone Acetonide | 2019 |
Effect of prophylactic antibiotics on polyacrylamide gel safety in facial augmentation.
Topics: Acrylic Resins; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Bacterial Infections; Biofilms; Cosmetic Techniques; Face; Female; Fluoroquinolones; Humans; Incidence; Inflammation; Injections; Male; Middle Aged; Moxifloxacin; Retrospective Studies; Young Adult | 2014 |
Moxifloxacin modulates inflammation during murine pneumonia.
Topics: Animals; Anti-Bacterial Agents; Fluoroquinolones; Immunity, Cellular; Inflammation; Lung; Mice; Mice, Inbred C57BL; Moxifloxacin; Pneumonia, Bacterial | 2014 |
A systemic defect in Toll-like receptor 4 signaling increases lipopolysaccharide-induced suppression of IL-2-dependent T-cell proliferation in COPD.
Topics: Anti-Bacterial Agents; Cell Proliferation; Fluoroquinolones; Humans; Inflammation; Interleukin-2; Lipopolysaccharides; Lymphocyte Activation; Moxifloxacin; p38 Mitogen-Activated Protein Kinases; Pulmonary Disease, Chronic Obstructive; Signal Transduction; Th1 Cells; Toll-Like Receptor 4 | 2016 |
Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.
Topics: Anti-Bacterial Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Feces; Fluoroquinolones; Humans; Inflammation; Intestines; Lactoferrin; Microbial Sensitivity Tests; Moxifloxacin; Quinolines | 2009 |
Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bronchoalveolar Lavage Fluid; Colony Count, Microbial; Cricetinae; Disease Models, Animal; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Inflammation; Lung; Male; Moxifloxacin; Neutrophils; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Quinolines; Survival Rate; Swine; Time Factors | 2010 |
Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model.
Topics: Adrenal Cortex Hormones; Animals; Anti-Infective Agents; Aza Compounds; Dexamethasone; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Inflammation; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Stem Cells; Time Factors; Vitreous Body | 2005 |
Anti-inflammatory effects of moxifloxacin and human beta-defensin 2 association in human lung epithelial cell line (A549) stimulated with lipopolysaccharide.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aza Compounds; beta-Defensins; Cell Adhesion; Cell Line; Cytokines; Epithelial Cells; Fluoroquinolones; Gene Expression; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Interleukin-8; Lipopolysaccharides; Lung; Moxifloxacin; Neutrophils; Quinolines; Tumor Necrosis Factor-alpha | 2007 |